» Articles » PMID: 25452867

Effect of Vitamin D3 Supplementation on Glycated Hemoglobin (HbA1c), Fructosamine, Serum Lipids, and Body Mass Index: a Randomized, Double-blinded, Placebo-controlled Trial Among Healthy Immigrants Living in Norway

Overview
Specialty Endocrinology
Date 2014 Dec 3
PMID 25452867
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Despite the suggested role of vitamin D in the prevention of diabetes and cardiovascular disease or its risk factors, the evidence is not consistent and there is a paucity of randomized controlled trials in this field. We aimed to investigate the effect of 16-week daily vitamin D3 supplementation on glycated hemoglobin (HbA1c), fructosamine, body mass index (BMI), and serum lipids.

Design: Double-blind, randomized, placebo-controlled trial.

Setting: Immigrant community centers in Oslo, Norway.

Participants: 251 healthy adults aged 18-50 years with a non-Western immigrant background. All participants performed the baseline test and 215 (86%) returned to the follow-up test.

Intervention: 16 weeks of daily oral supplementation with either 10 μg vitamin D3, 25 μg vitamin D3, or placebo.

Main Outcome Measures: Difference in absolute change during the 16-week intervention between the intervention groups combined (10 or 25 μg of vitamin D3/day) and placebo, in HbA1c, fructosamine, serum lipids (total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides), and BMI.

Results: A total of 215 (86%) participants completed the study. Serum 25-hydroxyvitamin D increased from 29 nmol/L at baseline to 49 nmol/L after intervention, with little change in the placebo group. However, there was no difference in change of HbA1c between those receiving vitamin D3 compared with placebo (mean difference: 0.01% (95% CI -0.04 to 0.06, p=0.7)). Neither did the vitamin D3 supplementation have any effect on the other end points: fructosamine, serum lipids, and BMI.

Conclusions: 16-week vitamin D3 supplementation to healthy immigrants from South Asia, the Middle East, or Africa and now living in Norway with low vitamin D status did not improve HbA1c, fructosamine, lipid profiles, or BMI. An updated meta-analysis of similar published trials showed that our results were generally consistent with those of other studies.

Trial Registration Number: NCT01263288.

Citing Articles

Vitamin D level regulates serum lipids discrepantly in adults with and without dyslipidemia.

Cheng Y, Lee T, Chien Y, Lee T, Chen Y Endocr Connect. 2023; 12(9).

PMID: 37410091 PMC: 10448594. DOI: 10.1530/EC-23-0013.


Migration health research in Norway: a scoping review.

Laue J, Diaz E, Eriksen L, Risor T Scand J Public Health. 2021; 51(3):381-390.

PMID: 34609260 PMC: 10251465. DOI: 10.1177/14034948211032494.


No Association between 25-Hydroxyvitamin D and Insulin Resistance or Thyroid Hormone Concentrations in a Romanian Observational Study.

Stoica R, Guja C, Pantea-Stoian A, Staden R, Popa-Tudor I, Stefan S Medicina (Kaunas). 2021; 57(1).

PMID: 33396784 PMC: 7824327. DOI: 10.3390/medicina57010025.


Effect of Vitamin D supplementation on reduction in levels of HbA1 in patients recently diagnosed with type 2 Diabetes Mellitus having asymptomatic Vitamin D deficiency.

Randhawa F, Mustafa S, Khan D, Hamid S Pak J Med Sci. 2017; 33(4):881-885.

PMID: 29067058 PMC: 5648957. DOI: 10.12669/pjms.334.12288.


Vitamin D intake and risk of CVD and all-cause mortality: evidence from the Caerphilly Prospective Cohort Study.

Guo J, Cockcroft J, Elwood P, Pickering J, Lovegrove J, Givens D Public Health Nutr. 2017; 20(15):2744-2753.

PMID: 28803595 PMC: 10261356. DOI: 10.1017/S1368980017001732.


References
1.
Holvik K, Meyer H, Haug E, Brunvand L . Prevalence and predictors of vitamin D deficiency in five immigrant groups living in Oslo, Norway: the Oslo Immigrant Health Study. Eur J Clin Nutr. 2004; 59(1):57-63. DOI: 10.1038/sj.ejcn.1602033. View

2.
Lips P . Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol. 2007; 103(3-5):620-5. DOI: 10.1016/j.jsbmb.2006.12.076. View

3.
Jorde R, Grimnes G . Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res. 2011; 50(4):303-12. DOI: 10.1016/j.plipres.2011.05.001. View

4.
Sneve M, Figenschau Y, Jorde R . Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol. 2008; 159(6):675-84. DOI: 10.1530/EJE-08-0339. View

5.
Wamberg L, Kampmann U, Stodkilde-Jorgensen H, Rejnmark L, Pedersen S, Richelsen B . Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - results from a randomized trial. Eur J Intern Med. 2013; 24(7):644-9. DOI: 10.1016/j.ejim.2013.03.005. View